Envista Holdings (NVST) Net Cash Flow (2019 - 2026)
Envista Holdings' (NVST) quarterly Net Cash Flow came in at -$117.8 million in Q2 2026, down 351.34% year-on-year from $46.9 million in Q2 2025, and down 275.04% quarter-over-quarter from $67.3 million in Q4 2025.
Envista Holdings (NVST) Net Cash Flow (2019 - 2026) Analysis & Trends
Envista Holdings' Net Cash Flow history runs 8 years deep, the most recent figure standing at -$117.8 million for Q2 2026.
- On a quarterly basis, Net Cash Flow fell 351.34% year-over-year to -$117.8 million in Q2 2026; TTM through Apr 2026 was -$38.0 million, a 130.38% decrease from a year earlier, with the FY2025 full-year figure at $53.7 million, down 69.87% from the prior year.
- Net Cash Flow fell to -$117.8 million in Q2 2026 per NVST's latest filing, from $67.3 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $185.0 million in Q3 2023 and bottomed at -$567.6 million in Q3 2022.
- The 5-year median for Net Cash Flow is $27.3 million (2025), against an average of -$929411.8.
- Across the five-year window, Net Cash Flow tumbled 616.47% in 2022 and surged 264.89% in 2023, its largest moves.
- Year by year, Net Cash Flow stood at $40.9 million in 2022, then soared by 126.65% to $92.7 million in 2023, then surged by 33.87% to $124.1 million in 2024, then plunged by 45.77% to $67.3 million in 2025, then plunged by 275.04% to -$117.8 million in 2026.
- Per Business Quant, the three latest NVST Net Cash Flow figures stand at -$117.8 million (Q2 2026), $67.3 million (Q4 2025), and $27.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 67.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 746.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 118.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 303.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 240.86 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -84.00 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 17.00 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -316.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -28.67 Mn |
| 10 | Envista Holdings | 4.29 Bn | 3.20 Bn | 390.10 Mn | -117.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -117.80 Mn |
| Apr 3, 2026 | -117.80 Mn |
| Dec 31, 2025 | 67.30 Mn |
| Dec 31, 2025 | 67.30 Mn |
| Sep 26, 2025 | 27.30 Mn |
| Sep 26, 2025 | 27.30 Mn |
| Jun 27, 2025 | -14.80 Mn |
| Jun 27, 2025 | -14.80 Mn |
| Mar 28, 2025 | -26.10 Mn |
| Mar 28, 2025 | -26.10 Mn |
| Dec 31, 2024 | 124.10 Mn |
| Dec 31, 2024 | 124.10 Mn |
| Sep 27, 2024 | -60.40 Mn |
| Sep 27, 2024 | -60.40 Mn |
| Jun 28, 2024 | 87.50 Mn |
| Jun 28, 2024 | 87.50 Mn |
| Mar 29, 2024 | 27.00 Mn |
| Mar 29, 2024 | 27.00 Mn |
| Dec 31, 2023 | 92.70 Mn |
| Dec 31, 2023 | 92.70 Mn |